INTELLIA THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 8Avg age 64Avg tenure 5.4y
JL
John Leonard
Chief Executive Officer
Age 68Since 2017-12-31Profile →
+12
Executives5
Board of directors8
JL
John Leonard→
Director/Board Member
Age 68Since 2014-06-30
FV
Frank Verwiel→
Chairman
Age 63Since 2020-01-31
JG
Jesse Goodman→
Director/Board Member
Age 74Since 2018-10-30
FC
Fred Cohen→
Director/Board Member
Age 69Since 2019-01-23
GK
Georgia Keresty→
Director/Board Member
Age 64Since 2021-04-08
MB
Muna Bhanji→
Director/Board Member
Age 63Since 2022-04-27
WC
William Chase→
Director/Board Member
Age 58Since 2023-04-13
BG
Brian Goff→
Director/Board Member
Age 57Since 2024-06-12
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| ARK Investment Management LLC | 10.38 % | 14,509,247 |
| BlackRock Advisors LLC | 7.665 % | 10,710,332 |
| STATE STREET CORPORATION | 4.955 % | 6,922,676 |
| Vanguard Portfolio Management LLC | 4.454 % | 6,223,325 |
| D.E. Shaw & Co., Inc. | 4.1 % | 5,728,177 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| Birgit Schultes | Chief Tech/Sci/R&D Officer | 2025-01-12 | - |
| David Lebwohl | Chief Tech/Sci/R&D Officer | 2020-04-29 | - |
| Edward Dulac | Director of Finance/CFO | 2024-07-21 | - |
| Frank Verwiel | Chairman | 2020-01-31 | - |
| John Leonard | Chief Executive Officer | 2017-12-31 | - |
| Kristy Wood | Chief Tech/Sci/R&D Officer | — | - |
| Brian Goff | Director/Board Member | 2024-06-12 | - |
| Fred Cohen | Director/Board Member | 2019-01-23 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 23.11Range 8–61Analysts 18
8Mean 23.1161
- Strong buy 1
- Buy 9
- Hold 6
- Sell 2
- Strong sell 2
Broker actions40 of 238
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Barclays | Initiated | Underweight | 8 | 2026-10-06 |
| Citizens | Reiterated | Market Outperform | 30 | 2026-09-09 |
| Wedbush | Maintained | Neutral | 13 | 2026-09-09 |
| HC Wainwright & Co. | Reiterated | Buy | 25 | 2026-09-09 |
| Citizens | Reiterated | Market Outperform | 30 | 2026-08-25 |
| Evercore ISI Group | Upgrade | Outperform | 24 | 2026-08-07 |
| Wolfe Research | Downgrade | Underperform | 9 | 2026-07-16 |
| Wedbush | Maintained | Neutral | 17 | 2026-07-10 |
| Canaccord Genuity | Maintained | Buy | 49 | 2026-06-16 |
| Citizens | Reiterated | Market Outperform | 30 | 2026-06-15 |
| Wedbush | Reiterated | Neutral | 12 | 2026-06-15 |
| HC Wainwright & Co. | Reiterated | Buy | 25 | 2026-06-15 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.